Stockreport

Humacyte Announces Publication of Long-Term Safety and Efficacy Results of Symvess® in Extremity Trauma Repair [Yahoo! Finance]

Humacyte, Inc.  (HUMA) 
PDF - After up to 36 months of follow-up, patients demonstrated high limb salvage, low rates of infection, no unprovoked structural failures - - Results represent first p [Read more]